Compare CKX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CKX | ICCM |
|---|---|---|
| Founded | 1930 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3M | 20.4M |
| IPO Year | 1996 | 2013 |
| Metric | CKX | ICCM |
|---|---|---|
| Price | $11.46 | $3.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 4.8K | ★ 254.2K |
| Earning Date | 05-11-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1125.00 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $838,543.00 | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | $382.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.66 | $0.13 |
| 52 Week High | $13.00 | $9.54 |
| Indicator | CKX | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 43.31 |
| Support Level | $10.21 | $0.63 |
| Resistance Level | $11.76 | $5.69 |
| Average True Range (ATR) | 0.44 | 0.27 |
| MACD | 0.03 | -0.22 |
| Stochastic Oscillator | 78.62 | 1.54 |
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.